A randomized phase 3 study of tipifarnib compared with best supportive care, including hydroxyurea, in the treatment of newly diagnosed acute myeloid leukemia in patients 70 years or older

J.L. Harousseau, G. Martinelli, W.W. Jedrzejczak, J.M. Brandwein, D. Bordessoule, T. Masszi, G.J. Ossenkoppele, J.A. Alexeeva, G. Beutel, J. Maertens, M.B. Vidriales, H. Dombret, X. Thomas, A.K. Burnett, T. Robak, N.K. Khuageva, A.K. Golenkov, E. Tothova, L. Mollgard, Y. ParkA. Bessems, P. De Porre, A.J. Howes

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)1166-1173
JournalBlood
Volume114
Issue number6
DOIs
Publication statusPublished - 2009

Cite this